MaxCyte, Inc.
COMMON · CUSIP 5777K1061
1
institutional holders
+0 vs Q1 2022
300.0k
shares reported held*
$1.4mreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $709.5k (+150.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.73.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2021 | 1 |
| Q4 2021 | 1 |
| Q1 2022 | 1 |
| Q2 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2021 | 1 | 0 |
| Q1 2022 | 1 | 0 |
| Q2 2022 | 1 | 0 |
Biggest buyers
| AWM Investment Company, Inc. | Added | +150.0k |
Biggest sellers
| None |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| AWM Investment Company, Inc. 0.22% of their portfolio | 300.0k $1.4m | Added +150.0k |